GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Housing for the 21st Century Act moves toward final Senate vote, including President Donald Trump's request to ban institutional investors from snatching up single-family homes....
Rogan says voters feel 'betrayed' by Trump's Iran campaign after he pledged 'no more wars' for years
Joe Rogan says voters for President Donald Trump feel "betrayed" by the U.S. military operation against Iran after Trump campaigned on no more wars in 2024....
The Trump administration's appeal come as it seeks to wind down the temporary protected status for hundreds of thousands of migrants living in the U.S....
